序号 |
标题 |
次数 |
作者 |
发布时间 |
73846 |
cas:150244-18-1,Sulfo-LC-SPDP,ADC定制 |
85 |
wyh |
2024-12-18 |
73847 |
负载虾青素的DHA-PC脂质体,Astaxanthin-embedded,DHA-PC,liposome,,DPC-AST |
127 |
axc |
2024-12-18 |
73848 |
二硫碳酸酯连接结构(-NH-CO-O-CH2CH2SS-) |
178 |
zyl |
2024-12-18 |
73849 |
DOTA-PEG4-BBN 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-聚乙二醇-蛙皮素 |
110 |
h |
2024-12-18 |
73850 |
Galβ1-3GlcNAcβ1-3Gal-O-(CH2)3-NH2.HCl |
74 |
zyl |
2024-12-18 |
73851 |
DOTA-PEG4-LLP2A |
101 |
h |
2024-12-18 |
73852 |
cas:70396-18-8 , Boc-Val-Ala-OH,(S)-2-((S)-2-((叔丁氧基羰基)氨基)-3-甲基丁酰胺基)丙酸 |
84 |
kx |
2024-12-18 |
73853 |
cas:1127247-34-0,2,5-Dioxopyrrolidin-1-yl 3-(2-methoxyethoxy)propanoate |
86 |
wyh |
2024-12-18 |
73854 |
Glcα1-4Glc-O-(CH2)3-NH-Biotin 麦芽糖DP2与生物素连接(接头-BT B)-科研定制 |
131 |
zyl |
2024-12-18 |
73855 |
cas:150114-97-9 ,Fmoc-Val-Ala-OH,Fmoc-L-缬氨酰-L-丙氨酸 |
89 |
kx |
2024-12-18 |
73856 |
E{E[c(RGDyK)]缀合大环螯合剂NOTA NOTA-E{E[c(RGDyK)] |
99 |
h |
2024-12-18 |
73857 |
Mal-amido-PEG8-Val-Gly (CAS: 2353409-54-6) |
156 |
WYQ |
2024-12-18 |
73858 |
(4E)-TCO-C3-PEG3-C3-amine |
73 |
zyl |
2024-12-18 |
73859 |
Fmoc-Ala-Pro-OH (CAS: 186023-44-9) |
149 |
WYQ |
2024-12-18 |
73860 |
BTP-7肽和细胞穿膜肽BR2共修饰的吲哚菁绿-米托蒽醌脂质体,BTP-7/BR2-ICG/MTO-LP |
102 |
axc |
2024-12-18 |
73861 |
Fmoc-PEG4-Val-Ala-PAB-PNP,N-芴甲氧羰基-四聚乙二醇-VAL-ALA-PAB-PNP |
71 |
kx |
2024-12-18 |
73862 |
Azide-PEG12-CH2CH2CH2-COOtBu |
66 |
zyl |
2024-12-18 |
73863 |
GNR-DOX-cRGD 阿霉素和cRGD共轭的金纳米棒 |
93 |
h |
2024-12-18 |
73864 |
Boc-Val-Cit-PAB-PNB(CAS:870487-10-8) |
95 |
WYQ |
2024-12-18 |
73865 |
MC (C5)-Val-Cit,CAS号:2504147-59-3 |
70 |
WYQ |
2024-12-18 |
73866 |
5-FAM-C3-SH |
135 |
zyl |
2024-12-18 |
73867 |
NOTA-gg Nle-CycMSHhex {(67)Ga-1,4,4DOTA-GGNle-CycMSHhex |
89 |
h |
2024-12-18 |
73868 |
cas:2353409-54-6 ,Mal-amido-PEG8-Val-Gly,马来酰亚胺-酰胺-八聚乙二醇-VAL-GLY |
116 |
kx |
2024-12-18 |
73869 |
MC-Val-Cit-PAB-OH(CAS:159857-80-4) |
114 |
WYQ |
2024-12-18 |
73870 |
叶酸靶向BQR-SS-DOX脂质体前药,BQR-SS-DOX/DSPE-PEG2000-FA,靶向脂质体定制服务 |
77 |
axc |
2024-12-18 |
73871 |
N3-C4-NHS ester,478801-48-8 |
79 |
zyl |
2024-12-18 |
73872 |
NOTA-GO 螯合剂NOTA偶联纳米石墨烯 |
101 |
h |
2024-12-18 |
73873 |
Fmoc-Ala-Ser(Psi(Me,Me)pro)-OH CAS:252554-78-2 |
70 |
WYQ |
2024-12-18 |
73874 |
CAS:863971-53-3,Fmoc-Val-Cit-PAB-PNP,抗体药物偶联物FMOC-VAL-CIT-PAB-PNP |
99 |
kx |
2024-12-18 |
73875 |
Cl-C6-PEG12-NHCO-C3-NHS,2727166-23-4烷基链 |
97 |
zyl |
2024-12-18 |
73876 |
PD-L1单抗修饰的尼洛替尼脂质体,LP-Nilotinib/αPDL1,αPDL1修饰的Nilotinib脂质体 |
114 |
axc |
2024-12-18 |
73877 |
Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB CAS:2055042-69-6 |
79 |
WYQ |
2024-12-18 |
73878 |
Cl-C6-PEG9-NH2 hydrochloride-烷基链 |
67 |
zyl |
2024-12-18 |
73879 |
Fmoc-Val-Cit-PAB-OH CAS:159858-22-7 |
75 |
WYQ |
2024-12-18 |
73880 |
CAS:159857-80-4,MC-Val-Cit-PAB-OH ,MC-VAL-CIT-PAB中间体 |
67 |
kx |
2024-12-18 |
73881 |
Biotin-C6-amine,65953-56-2烷基链试剂 |
89 |
zyl |
2024-12-18 |
73882 |
鹿茸多肽脂质体水凝胶,Velvet,antler,peptides,liposome,hydrogel,VAP-Lip-Gel,脂质体纳米载体定制服务 |
93 |
axc |
2024-12-18 |
73883 |
NOTA-Bn-SCN-Aoc-BN(7-14)S-2-(4-异硫氰基苄基)-NOTA偶联BN(7-14) |
85 |
h |
2024-12-18 |
73884 |
CAS:2055048-57-0,Fmoc-PEG4-Ala-Ala-Asn-PAB ,芴甲氧羰基-四聚乙二醇-ALA-ALA ASN-PAB |
73 |
kx |
2024-12-18 |
73885 |
NH2-PEG3-C6-Cl,1261350-60-0 |
68 |
zyl |
2024-12-18 |
73886 |
MC-Val-Cit-PAB-PNP(CAS:159857-81-5) |
94 |
WYQ |
2024-12-18 |
73887 |
NOTA-HSA 大环配体NOTA偶联人血清白蛋白 |
71 |
h |
2024-12-18 |
73888 |
SPDP-Val-Cit-PAB-OH(N-琥珀酰亚胺基-3-(2-吡啶二硫)丙酸) |
57 |
WYQ |
2024-12-18 |
73889 |
鹿茸多肽脂质体,Velvet,antler,peptides,liposome,VAP-Lip,多功能载药脂质体定制服务 |
109 |
axc |
2024-12-18 |
73890 |
NOTA-西妥昔单抗-800CW NOTA-cetuximab-800CW |
64 |
h |
2024-12-18 |